Gastric cancer remains highly prevalent and accounts for a notable proportion of global
cancer mortality. This cancer is also associated with poor survival rates. Understanding the …

Objective Gastric cancer is a major gastrointestinal malignancy for which targeted therapies
are emerging as treatment options. This study sought to identify the most prevalent …

Carcinoma of the stomach is still the second most common cause of cancer death
worldwide, although the incidence and mortality have fallen dramatically over the last 50 …

We investigated expression profiles of microRNA (miRNA) in gastric carcinomas by use of a
miRNA microarray platform covering a total of 470 human miRNAs. We identified 39 …

A method of treating a patient who has non-small cell lung carcinoma (NSCLC), lung cancer,
gastric cancer, and/or glioblastoma includes administering to said patient a composition …

Expression microarrays are widely used for investigating the candidate molecular targets in
human cancer. While genome-wide expression signatures screened by gene set enrichment …

The present invention relates to peptides, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …

Farnesyl-diphosphate farnesyltransferase 1 (FDFT1, squalene synthase), a membrane-
associated enzyme, synthesizes squalene via condensation of two molecules of farnesyl …

Background Intra-tumor heterogeneity is a potential cause for failure of targeted therapy in
gastric cancer, but the extent of heterogeneity of established (HER2) or potential (EGFR …

Breast cancer is the most common cancer in women and its incidence rates are rapidly
increasing in China. Understanding the molecular mechanisms of breast cancer …